Literature DB >> 2475575

Isolation and characterization of a distinct immunoregulatory isoform of alpha-fetoprotein produced by the normal fetus.

N S van Oers1, B L Cohen, R A Murgita.   

Abstract

In this report, we examine the functional significance of the molecular microheterogeneity of alpha-fetoprotein (AFP). In doing so, we have taken the direct approach of purifying the naturally occurring isomeric forms of fetal-derived AFP using a preparative anion exchange column linked to an automated fast protein liquid chromatography (FPLC) system followed by parallel testing of each isolated molecular variant for in vitro immunoregulatory activity. The data obtained demonstrate the presence of seven distinct variants of AFP as defined by their retention volumes on FPLC elution profiles, by their pIs on analytical IEF gels, and by Western blot analysis. Molecular mass determination by SDS-PAGE showed each isomer to be equivalent in size to 69,000-dalton native unfractionated AFP molecules. All the immunosuppressive activity of AFP was localized to a single variant representing only 6% of the total composition of native AFP. The immunoregulating isomer termed AFP-1 was the least acidic of the seven isolated variants with a pI of 5.1 and displayed a sialic acid content of 1 mol/mol of protein. The inhibitory activity of AFP-1 could be readily measured on T cell-dependent antibody synthesis, Con A-induced stimulation of Lyt-1+23- thymocyte DNA synthesis, and lymphokine-activated NK cell activity. All other isomers were without effect in these test systems. The immunosuppressive AFP-1 isomer also displayed the strongest growth-promoting influence on cultured bone marrow lymphocytes. There was no correlation between functional activity and degree of expression of sialic acid residues on the AFP molecules. These findings demonstrate that the immunoregulating function of AFP is confined to a distinct and relatively small subpopulation of native AFP molecules and should therefore contribute to the resolution of outstanding questions regarding the structure/function relationship of this onco-fetal glycoprotein.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2475575      PMCID: PMC2189419          DOI: 10.1084/jem.170.3.811

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  42 in total

1.  Identification of albumin as the serum factor essential for the growth of activated human lymphocytes.

Authors:  H Spieker-Polet; H Polet
Journal:  J Biol Chem       Date:  1976-02-25       Impact factor: 5.157

2.  Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids.

Authors:  D AMINOFF
Journal:  Biochem J       Date:  1961-11       Impact factor: 3.857

3.  Isoelectric focusing of human fetoprotein: an aid in purification and characterization of microheterogeneity.

Authors:  E Alpert; J W Drysdale; K J Isselbacher
Journal:  Ann N Y Acad Sci       Date:  1973-06-15       Impact factor: 5.691

4.  Foetoneonatal oestradiol-binding protein in mouse brain cytosol is alpha foetoprotein.

Authors:  B Attardi; E Ruoslahti
Journal:  Nature       Date:  1976-10-21       Impact factor: 49.962

5.  Immunosuppression by mouse sialylated alpha-foetoprotein.

Authors:  E F Zimmerman; M Voorting-Hawking; J G Michael
Journal:  Nature       Date:  1977-01-27       Impact factor: 49.962

6.  Developmental microheterogeneity of mouse alpha-fetoproteins: purification and partial characterization.

Authors:  E F Zimmerman; D Bowen; J R Wilson; M M Madappally
Journal:  Biochemistry       Date:  1976-12-14       Impact factor: 3.162

7.  Alpha-feto-protein during development and in disease.

Authors:  A Adinolfi; M Adinolfi
Journal:  J Med Genet       Date:  1975-06       Impact factor: 6.318

8.  Human alpha-fetoprotein as a modulator of human lymphocyte transformation: correlation of biological potency with electrophoretic variants.

Authors:  E P Lester; J B Miller; S Yachnin
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

9.  The immunosuppressive role of alpha-fetoprotein during pregnancy.

Authors:  R A Murgita
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

10.  Suppression of the immune response by alpha-fetoprotein on the primary and secondary antibody response.

Authors:  R A Murgita; T B Tomasi
Journal:  J Exp Med       Date:  1975-02-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Alpha-fetoprotein: a renaissance.

Authors:  A A Terentiev; N T Moldogazieva
Journal:  Tumour Biol       Date:  2013-06-14

2.  The immunomodulatory activity of human amniotic fluid can be correlated with transforming growth factor-beta 1 (TGF-beta 1) and beta 2 activity.

Authors:  A K Lang; R F Searle
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

3.  A transforming growth factor beta 2 (TGF-beta 2)-like immunosuppressive factor in amniotic fluid and localization of TGF-beta 2 mRNA in the pregnant uterus.

Authors:  D J Altman; S L Schneider; D A Thompson; H L Cheng; T B Tomasi
Journal:  J Exp Med       Date:  1990-11-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.